Scientists successfully built the smallest X-ray interferometer to measure how X-rays interact with atomic nuclei. This breakthrough technology enables precise measurement of X-ray refraction and provides new avenues for research.
A team of researchers from KAIST has developed a DNA-based molecular computer that can operate at a much smaller scale than conventional semiconductor devices. The system enables both computation and memory within the same device, opening up new possibilities for future computing technologies in bio and medical applications.
A systematic review from Flinders University supports effective AI systems for cardiovascular care, providing more accurate diagnoses and proactive interventions. The study highlights the importance of strong governance, workforce readiness, and organisational support for sustainable implementation.
Fossils of a toothed platypus species, Obdurodon insignis, reveal that it lived 25 million years ago in a diverse ecosystem with other animals like lungfish, dolphins, and flamingos. The discovery provides new insights into the evolutionary history of modern platypuses.
A new study found significant socio-economic inequalities in accessing mental health care, with children from deprived areas more likely to have their referrals rejected or experience worse clinical outcomes. Younger children under 11 are also less likely to receive help, hindering early intervention efforts.
A study identifies fucosylated immunoglobulin G (IgG) as a key mediator contributing to adipose tissue dysfunction during aging. Fucosylation levels of IgG were significantly increased in aged mice, exacerbating inflammation and fibrosis while inhibiting adipogenesis.
A new AI-powered framework integrates phenotype-target coupled screening for efficient discovery of Chinese herbal medicine-derived drugs. The approach leverages advanced technologies, including AI-driven analysis and high-throughput screening, to identify promising candidates and uncover mechanism clues.
Researchers have developed glycocalyx engineering strategies to enhance immune cell functions against B lymphoma. By customizing the NK-92MI glycocalyx, they created selectin ligands that improved in vivo elimination of mouse xenografts, offering a cost-effective candidate for cancers with reduced CD19 antigen levels.